Funded Tech Companies
Elysium Therapeutics
Looking for the VC firms that provided funding to Elysium Therapeutics? Private investors joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Elysium Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
57 Ogallala Rd
Lyons, CO 80540
US
Lyons, CO 80540
US
Phone
Website
Email Address
Company Background Information
Overview
Elysium's mission is to reduce suffering from severe acute pain, opioid-use disorder (OUD), and fatal opioid overdose by developing first- or best-in-class products with profiles that address the key limitations and dangers associated with opioids used today. Our pipeline consists of 3 diverse platforms with broad applicability across several areas of significant unmet need: Technologies 1. O2P� (Oral Overdose Protection) -- Lead platform Traditional opioids are easy to abuse, with euphoria and risk of respiratory depression increasing with every pill consumed. O2P provides self-limiting exposure to active opioid and prevents overdose. 2. XpiRx� (Forced Expiration) 70-year half-life of traditional opioids creates a surplus supply of readily available pills that can end up on the streets. XpiRx opioids, whose potency expires after the prescribed-use period, reduce abuse and prevent fatal overdoses. 3. SOOPR� (Synthetic Opioid Overdose Prevention and Rescue) Existing rescue agents are
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/28/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Greg Sturmer
Co-Founder
Tom Jenkins
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs